Microneedle Flu Vaccine Market Report

Global Microneedle Flu Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：218
  • REPORT CODE：GMM832024
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Microneedle Flu Vaccine market report explains the definition, types, applications, major countries, and major players of the Microneedle Flu Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Debiotech

    • FluGen

    • GC Pharma

    • Microdermics and OraSure Technologies

    • Becton Dickinson and Company

    • NanoPass Technologies

    • Corium International

    • CosMED Pharmaceuticals

    • Sanofi

    By Type:

    • Solid Microneedle

    • Hollow Microneedle

    • Coated Microneedle

    • Dissolving Microneedle

    By End-User:

    • Influenza A

    • Influenza B

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Microneedle Flu Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Microneedle Flu Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Microneedle Flu Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Microneedle Flu Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Microneedle Flu Vaccine Market- Recent Developments

    • 6.1 Microneedle Flu Vaccine Market News and Developments

    • 6.2 Microneedle Flu Vaccine Market Deals Landscape

    7 Microneedle Flu Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Microneedle Flu Vaccine Key Raw Materials

    • 7.2 Microneedle Flu Vaccine Price Trend of Key Raw Materials

    • 7.3 Microneedle Flu Vaccine Key Suppliers of Raw Materials

    • 7.4 Microneedle Flu Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Microneedle Flu Vaccine Cost Structure Analysis

      • 7.5.1 Microneedle Flu Vaccine Raw Materials Analysis

      • 7.5.2 Microneedle Flu Vaccine Labor Cost Analysis

      • 7.5.3 Microneedle Flu Vaccine Manufacturing Expenses Analysis

    8 Global Microneedle Flu Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Microneedle Flu Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Microneedle Flu Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Microneedle Flu Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Microneedle Flu Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Solid Microneedle Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hollow Microneedle Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Coated Microneedle Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Dissolving Microneedle Consumption and Growth Rate (2017-2022)

    • 9.2 Global Microneedle Flu Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Influenza A Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Influenza B Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Microneedle Flu Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Microneedle Flu Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Microneedle Flu Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.2 UK Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.5 France Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Microneedle Flu Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.3 India Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Microneedle Flu Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Microneedle Flu Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Microneedle Flu Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Microneedle Flu Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Microneedle Flu Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Microneedle Flu Vaccine Consumption (2017-2022)

    11 Global Microneedle Flu Vaccine Competitive Analysis

    • 11.1 Debiotech

      • 11.1.1 Debiotech Company Details

      • 11.1.2 Debiotech Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Debiotech Microneedle Flu Vaccine Main Business and Markets Served

      • 11.1.4 Debiotech Microneedle Flu Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 FluGen

      • 11.2.1 FluGen Company Details

      • 11.2.2 FluGen Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 FluGen Microneedle Flu Vaccine Main Business and Markets Served

      • 11.2.4 FluGen Microneedle Flu Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GC Pharma

      • 11.3.1 GC Pharma Company Details

      • 11.3.2 GC Pharma Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GC Pharma Microneedle Flu Vaccine Main Business and Markets Served

      • 11.3.4 GC Pharma Microneedle Flu Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Microdermics and OraSure Technologies

      • 11.4.1 Microdermics and OraSure Technologies Company Details

      • 11.4.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Main Business and Markets Served

      • 11.4.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Becton Dickinson and Company

      • 11.5.1 Becton Dickinson and Company Company Details

      • 11.5.2 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Becton Dickinson and Company Microneedle Flu Vaccine Main Business and Markets Served

      • 11.5.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 NanoPass Technologies

      • 11.6.1 NanoPass Technologies Company Details

      • 11.6.2 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 NanoPass Technologies Microneedle Flu Vaccine Main Business and Markets Served

      • 11.6.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Corium International

      • 11.7.1 Corium International Company Details

      • 11.7.2 Corium International Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Corium International Microneedle Flu Vaccine Main Business and Markets Served

      • 11.7.4 Corium International Microneedle Flu Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 CosMED Pharmaceuticals

      • 11.8.1 CosMED Pharmaceuticals Company Details

      • 11.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Main Business and Markets Served

      • 11.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Sanofi

      • 11.9.1 Sanofi Company Details

      • 11.9.2 Sanofi Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Sanofi Microneedle Flu Vaccine Main Business and Markets Served

      • 11.9.4 Sanofi Microneedle Flu Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Microneedle Flu Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Microneedle Flu Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Solid Microneedle Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Hollow Microneedle Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Coated Microneedle Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Dissolving Microneedle Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Microneedle Flu Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Influenza A Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Influenza B Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Microneedle Flu Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Microneedle Flu Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Microneedle Flu Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Microneedle Flu Vaccine

    • Figure of Microneedle Flu Vaccine Picture

    • Table Global Microneedle Flu Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Microneedle Flu Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Solid Microneedle Consumption and Growth Rate (2017-2022)

    • Figure Global Hollow Microneedle Consumption and Growth Rate (2017-2022)

    • Figure Global Coated Microneedle Consumption and Growth Rate (2017-2022)

    • Figure Global Dissolving Microneedle Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza A Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza B Consumption and Growth Rate (2017-2022)

    • Figure Global Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Table North America Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Figure United States Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Figure Germany Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Figure China Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Microneedle Flu Vaccine Consumption by Country (2017-2022)

    • Figure Australia Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Microneedle Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Debiotech Company Details

    • Table Debiotech Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Debiotech Microneedle Flu Vaccine Main Business and Markets Served

    • Table Debiotech Microneedle Flu Vaccine Product Portfolio

    • Table FluGen Company Details

    • Table FluGen Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table FluGen Microneedle Flu Vaccine Main Business and Markets Served

    • Table FluGen Microneedle Flu Vaccine Product Portfolio

    • Table GC Pharma Company Details

    • Table GC Pharma Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GC Pharma Microneedle Flu Vaccine Main Business and Markets Served

    • Table GC Pharma Microneedle Flu Vaccine Product Portfolio

    • Table Microdermics and OraSure Technologies Company Details

    • Table Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Microdermics and OraSure Technologies Microneedle Flu Vaccine Main Business and Markets Served

    • Table Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio

    • Table Becton Dickinson and Company Company Details

    • Table Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson and Company Microneedle Flu Vaccine Main Business and Markets Served

    • Table Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio

    • Table NanoPass Technologies Company Details

    • Table NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table NanoPass Technologies Microneedle Flu Vaccine Main Business and Markets Served

    • Table NanoPass Technologies Microneedle Flu Vaccine Product Portfolio

    • Table Corium International Company Details

    • Table Corium International Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corium International Microneedle Flu Vaccine Main Business and Markets Served

    • Table Corium International Microneedle Flu Vaccine Product Portfolio

    • Table CosMED Pharmaceuticals Company Details

    • Table CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CosMED Pharmaceuticals Microneedle Flu Vaccine Main Business and Markets Served

    • Table CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Microneedle Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Microneedle Flu Vaccine Main Business and Markets Served

    • Table Sanofi Microneedle Flu Vaccine Product Portfolio

    • Figure Global Solid Microneedle Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hollow Microneedle Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coated Microneedle Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dissolving Microneedle Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza A Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Microneedle Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Microneedle Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US